Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Endogenous galactose formation in galactose-1-phosphate uridyltransferase deficiency.

Schadewaldt P, Kamalanathan L, Hammen HW, Kotzka J, Wendel U.

Arch Physiol Biochem. 2014 Dec;120(5):228-39. doi: 10.3109/13813455.2014.962547. Epub 2014 Sep 30.

PMID:
25268296
2.

Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.

Kempf K, Schloot NC, Gärtner B, Keil R, Schadewaldt P, Martin S.

J Hum Nutr Diet. 2014 Apr;27 Suppl 2:21-7. doi: 10.1111/jhn.12145. Epub 2013 Aug 2.

PMID:
23909831
3.

Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M.

Diabetes. 2013 Jul;62(7):2240-8. doi: 10.2337/db12-1179. Epub 2013 Mar 1.

4.

Indirect calorimetry in humans: a postcalorimetric evaluation procedure for correction of metabolic monitor variability.

Schadewaldt P, Nowotny B, Strassburger K, Kotzka J, Roden M.

Am J Clin Nutr. 2013 Apr;97(4):763-73. doi: 10.3945/ajcn.112.035014. Epub 2013 Feb 27.

PMID:
23446893
5.

Differential glycomics of epithelial membrane glycoproteins from urinary exovesicles reveals shifts toward complex-type N-glycosylation in classical galactosemia.

Staubach S, Schadewaldt P, Wendel U, Nohroudi K, Hanisch FG.

J Proteome Res. 2012 Feb 3;11(2):906-16. doi: 10.1021/pr200711w. Epub 2011 Dec 2.

PMID:
22087537
6.

Features and outcome of galactokinase deficiency in children diagnosed by newborn screening.

Hennermann JB, Schadewaldt P, Vetter B, Shin YS, Mönch E, Klein J.

J Inherit Metab Dis. 2011 Apr;34(2):399-407. doi: 10.1007/s10545-010-9270-8. Epub 2011 Feb 3.

PMID:
21290184
7.

Longitudinal assessment of intellectual achievement in patients with classical galactosemia.

Schadewaldt P, Hoffmann B, Hammen HW, Kamp G, Schweitzer-Krantz S, Wendel U.

Pediatrics. 2010 Feb;125(2):e374-81. doi: 10.1542/peds.2008-3325. Epub 2010 Jan 25.

PMID:
20100763
8.

Urinary excretion of pentose phosphate pathway-associated polyols in early postnatal life.

Koy A, Waldhaus A, Hammen HW, Wendel U, Mayatepek E, Schadewaldt P.

Neonatology. 2009;95(3):256-61. doi: 10.1159/000167789. Epub 2008 Nov 5.

PMID:
18987485
9.

Biochemical monitoring of pregnancy and breast feeding in five patients with classical galactosaemia--and review of the literature.

Schadewaldt P, Hammen HW, Kamalanathan L, Wendel U, Schwarz M, Bosch AM, Guion N, Janssen M, Boers GH.

Eur J Pediatr. 2009 Jun;168(6):721-9. doi: 10.1007/s00431-008-0832-9. Epub 2008 Sep 24.

PMID:
18813948
10.

Description of the mutations in 15 subjects with variant forms of maple syrup urine disease.

Flaschker N, Feyen O, Fend S, Simon E, Schadewaldt P, Wendel U.

J Inherit Metab Dis. 2007 Nov;30(6):903-9. Epub 2007 Oct 8.

PMID:
17922217
11.

Urinary excretion of the nitrotyrosine metabolite 3-nitro-4-hydroxyphenylacetic acid in preterm and term infants.

Hoehn T, Janssen S, Mani AR, Brauers G, Moore KP, Schadewaldt P, Mayatepek E.

Neonatology. 2008;93(2):73-6. Epub 2007 Aug 6.

PMID:
17684421
12.

Variant maple syrup urine disease (MSUD)--the entire spectrum.

Simon E, Flaschker N, Schadewaldt P, Langenbeck U, Wendel U.

J Inherit Metab Dis. 2006 Dec;29(6):716-24. Epub 2006 Oct 25.

PMID:
17063375
13.

Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.

Hoffmann B, Helbling C, Schadewaldt P, Wendel U.

Pediatr Res. 2006 Jan;59(1):17-20. Epub 2005 Dec 2.

PMID:
16326996
14.

Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.

Simon E, Wendel U, Schadewaldt P.

Turk J Pediatr. 2005 Jan-Mar;47(1):8-13.

PMID:
15884622
15.

Neonatal screening, clinical features and genetic testing for galactosemia.

Zaffanello M, Zamboni G, Schadewaldt P, Borgiani P, Novelli G.

Genet Med. 2005 Mar;7(3):211-2. No abstract available.

PMID:
15775761
16.

Galactonate determination in urine by stable isotope dilution gas chromatography-mass spectrometry.

Schadewaldt P, Hammen HW, Stolpmann S, Kamalanathan L, Wendel U.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):249-55.

PMID:
14751793
17.

Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients.

Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U.

Mol Genet Metab. 2004 Jan;81(1):31-44.

PMID:
14728989
18.

Stable-isotope dilution analysis of galactose metabolites in human erythrocytes.

Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U.

Rapid Commun Mass Spectrom. 2003;17(24):2833-8.

PMID:
14673834
19.

Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents and healthy subjects.

Schadewaldt P, Killius S, Kamalanathan L, Hammen HW, Strassburger K, Wendel U.

J Inherit Metab Dis. 2003;26(5):459-79.

PMID:
14518827
20.

Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease.

Henneke M, Flaschker N, Helbling C, Müller M, Schadewaldt P, Gärtner J, Wendel U.

Hum Mutat. 2003 Nov;22(5):417.

PMID:
14517957
21.

A woman with untreated galactosaemia.

Lee PJ, Lilburn M, Wendel U, Schadewaldt P.

Lancet. 2003 Aug 9;362(9382):446. No abstract available. Erratum in: Lancet. 2004 Jul 24;364(9431):330.

PMID:
12927432
22.

Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.

Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U.

Pediatr Res. 2001 May;49(5):627-35.

PMID:
11328944
23.

Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.

Bodner-Leidecker A, Wendel U, Saudubray JM, Schadewaldt P.

J Inherit Metab Dis. 2000 Dec;23(8):805-18.

PMID:
11196106
24.

Analysis of (S)- and (R)-3-methyl-2-oxopentanoate enantiomorphs in body fluids.

Schadewaldt P.

Methods Enzymol. 2000;324:33-9. No abstract available.

PMID:
10989415
25.

Determination of branched-chain L-amino-acid aminotransferase activity.

Schadewaldt P.

Methods Enzymol. 2000;324:23-32. No abstract available.

PMID:
10989414
26.

[Is homocysteine a risk factor for coronary heart disease in patients with terminal renal failure?].

Klusmann A, Ivens K, Schadewaldt P, Grabensee B, Heering P.

Med Klin (Munich). 2000 Apr 15;95(4):189-94. German.

PMID:
10808299
27.

Analysis of concentration and (13)C enrichment of D-galactose in human plasma.

Schadewaldt P, Hammen HW, Loganathan K, Bodner-Leidecker A, Wendel U.

Clin Chem. 2000 May;46(5):612-9.

28.

Formation of L-alloisoleucine in vivo: an L-[13C]isoleucine study in man.

Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U.

Pediatr Res. 2000 Feb;47(2):271-7.

PMID:
10674358
29.

Liver transplantation in maple syrup urine disease.

Wendel U, Saudubray JM, Bodner A, Schadewaldt P.

Eur J Pediatr. 1999 Dec;158 Suppl 2:S60-4. Review.

PMID:
10603101
30.

Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.

Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U.

Clin Chem. 1999 Oct;45(10):1734-40.

31.

Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.

Schadewaldt P, Hammen HW, Ott AC, Wendel U.

J Inherit Metab Dis. 1999 Aug;22(6):706-22.

PMID:
10472531
32.

Preface.

Schadewaldt P.

Isotopes Environ Health Stud. 1999 Sep;35(1-2):1. doi: 10.1080/10256019908234075. No abstract available.

PMID:
29016213
33.

Diurnal changes in plasma amino acids in maple syrup urine disease.

Schwahn B, Wendel U, Schadewaldt P, Falkenberg N, Mönch E.

Acta Paediatr. 1998 Dec;87(12):1245-6.

PMID:
9894823
34.

Significance of diagnostic parameters in [13C]octanoic acid gastric emptying breath tests.

Schommartz B, Ziegler D, Schadewaldt P.

Isotopes Environ Health Stud. 1998;34(1-2):135-43.

PMID:
9854848
36.

Metabolism of branched-chain amino acids in maple syrup urine disease.

Schadewaldt P, Wendel U.

Eur J Pediatr. 1997 Aug;156 Suppl 1:S62-6. Review.

PMID:
9266218
37.

Significance of diagnostic parameters in [(13)c]octanoic Acid gastric emptying breath tests*.

Schommartz B, Ziegler D, Schadewaldt P.

Isotopes Environ Health Stud. 1997 Jul;33(1-2):135-43. doi: 10.1080/10256019708036341.

PMID:
22087491
39.

Compartmental approach for evaluation of plasma kinetics and (13)co(2)-exhalation after oral loading with L-[1-(13)c]leucine.

Bodner A, Renn W, Wendel U, Schadewaldt P.

Isotopes Environ Health Stud. 1996 Aug;32(2-3):237-46. doi: 10.1080/10256019608036316.

PMID:
22088115
40.

Determination of R- and S-3-methyl-2-oxopentanoate enantiomers in human plasma: suitable method for label enrichment analysis.

Schadewaldt P, Wendel U, Hammen HW.

J Chromatogr B Biomed Appl. 1996 Jul 12;682(2):209-18.

PMID:
8844412
41.

[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function.

Ziegler D, Schadewaldt P, Pour Mirza A, Piolot R, Schommartz B, Reinhardt M, Vosberg H, Brösicke H, Gries FA.

Diabetologia. 1996 Jul;39(7):823-30.

PMID:
8817107
42.
43.

Enzymatic method for determination of branched-chain amino acid aminotransferase activity.

Schadewaldt P, Hummel W, Wendel U, Adelmeyer F.

Anal Biochem. 1995 Sep 20;230(2):199-204.

PMID:
7503408
44.

Enzymatic-chemical preparation of quinoxaline derivatives from L-amino acids for gas chromatographic-mass spectrometric analyses.

Schadewaldt P, Hammen HW, Wendel U, Matthiesen U.

Anal Biochem. 1995 Aug 10;229(2):153-61.

PMID:
7485967
45.

Human branched-chain L-amino acid aminotransferase: Activity and subcellular localization in cultured skin fibroblasts.

Schadewaldt P, Wendel U, Hammen HW.

Amino Acids. 1995 Jun;9(2):147-60. doi: 10.1007/BF00805836.

PMID:
24178815
46.
47.

Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.

Heering P, Schadewaldt P, Bach D, Grabensee B.

Clin Investig. 1993 Dec;71(12):1010-5.

PMID:
8124053
48.

Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease.

Wendel U, Even G, Langenbeck U, Schadewaldt P, Hummel W.

Clin Chim Acta. 1992 Jun 15;208(1-2):85-91.

PMID:
1638756
49.

Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.

Schadewaldt P, Dalle-Feste C, Langenbeck U, Wendel U.

Pediatr Res. 1991 Nov;30(5):430-4.

PMID:
1754297
50.

Supplemental Content

Loading ...
Support Center